You have 9 free searches left this month | for more free features.

non-diabetic

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular

Not yet recruiting
  • SGLT2 Inhibitiors Remodeling Effect
  • Chronic Heart Disease
  • Sodium-glucose cotransporter 2 inhibitor
  • (no location specified)
Nov 14, 2023

Non Alcoholic Steatohepatitis Trial in Tanta (Diosmin, Placebo)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Tanta, Egypt
    Tanta University
Jul 5, 2023

Diabetes Trial (Lance CLEAR dental implant)

Not yet recruiting
  • Diabetes
  • Lance CLEAR dental implant
  • (no location specified)
Aug 4, 2023

Gastric Ultrasound in Diabetic and Non-Diabetic Pregnant Women

Recruiting
  • Gastric Ultrasonography
  • +4 more
  • Gastric ultrasonography
  • Sariyer, Istanbul, Turkey
    Sisli Hamidiye Etfal Training and Research Hospital
Jul 29, 2023

Lipodystrophy, Dunnigan Syndrome Trial in Saint-Pierre (Bood and urine sampling)

Recruiting
  • Lipodystrophy
  • Dunnigan Syndrome
  • Bood and urine sampling
  • Saint-Pierre, Réunion
    CHU La Réunion DRCI
Oct 27, 2023

PsA (Psoriatic Arthritis) Trial (Metformin)

Not yet recruiting
  • PsA (Psoriatic Arthritis)
  • (no location specified)
Aug 4, 2023

Overweight or Obesity Trial in Shijiazhuang (TG103 22.5 mg, Placebo)

Not yet recruiting
  • Overweight or Obesity
  • TG103 22.5 mg
  • Placebo
  • Shijiazhuang, Hebei, China
    Clinical Trials Information Group
Aug 18, 2023

Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Chronic Kidney Diseases
  • Empagliflozin 10 MG
  • Placebo
  • (no location specified)
Oct 30, 2023

Fatty Liver Disease Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Fatty Liver Disease
  • Empagliflozin 10 MG
  • (no location specified)
Jan 19, 2023

Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))

Not yet recruiting
  • Metabolic Associated Fatty Liver Disease
  • dapagliflozin (Forxiga)
  • (no location specified)
Mar 13, 2023

Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)

Not yet recruiting
  • Nephrotic Syndrome
  • Dapagliflozin and Standard therapy (ACEI or ARB).
  • Standard Therapy (ACEI or ARB).
  • (no location specified)
Jul 26, 2023

Septic Shock Trial (Metformin, standardized protocol)

Not yet recruiting
  • Septic Shock
  • (no location specified)
Oct 6, 2022

Diastolic Dysfunction, Obesity Trial in Cairo (Metformin)

Not yet recruiting
  • Diastolic Dysfunction
  • Obesity
  • Cairo, Egypt
    Cairo University Hospitals
Apr 26, 2023

Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)

Completed
  • Normoglycemia
  • T2DM (Type 2 Diabetes Mellitus)
  • Bread
  • Mango
  • New Delhi, Delhi, India
    Fortis CDOC Hospital
Sep 20, 2023

Residual Gastric Volume Measured by Ultrasound in Diabetic

Recruiting
  • Diabetes Mellitus
    • Salamanca, Spain
      IBSAL
    Jun 22, 2022

    Periodontal Disease and Diabetes Mellitus

    Completed
    • Periodontitis, Adult
    • GCF levels of fetuin A and hsCRP evaluation
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Sep 26, 2023

    Chronic Kidney Diseases Trial in Lyon (impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients)

    Not yet recruiting
    • Chronic Kidney Diseases
    • impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients
    • Lyon, France
      Nephrology department, Hôpital Lyon Sud, Hospices Civils de Lyon
    Jul 28, 2023

    Corneal Endothelial Changes After Phacoemulsification Trial in Cairo (Specular biomicroscopy)

    Recruiting
    • Corneal Endothelial Changes After Phacoemulsification
    • Specular biomicroscopy
    • Cairo, Egypt
      Cairo University
    Jun 21, 2022

    Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)

    Not yet recruiting
    • Non Alcoholic Steatohepatitis
    • Pioglitazone 30mg
    • Empagliflozin 10 MG
    • Tanta, Gharbiya, Egypt
      Tanta University
    Nov 2, 2022

    Chronic Kidney Diseases, Bone Diseases, Metabolic Trial in Mansoura (Dapagliflozin 10mg Tab, Placebo)

    Active, not recruiting
    • Chronic Kidney Diseases
    • Bone Diseases, Metabolic
    • Dapagliflozin 10mg Tab
    • Placebo
    • Mansoura, Aldakahliya, Egypt
      Urology and Nephrology center, Mansoura University
    Feb 16, 2023

    SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )

    Active, not recruiting
    • SLE
    • +2 more
    • Mansoura, Egypt
      Urology and Nephrology Center
    Feb 18, 2023

    Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

    Active, not recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Montclair, California
    • +12 more
    Oct 11, 2022

    Dapagliflozin in the Treatment of Heart Failure

    Active, not recruiting
    • Heart Failure
      • Cairo, Egypt
        cardiology department at Ain Shams university hospitals
      Feb 5, 2023

      Polycystic Ovary Syndrome Trial in Shenyang (Canagliflozin combined with metformin, metformin)

      Completed
      • Polycystic Ovary Syndrome
      • Shenyang, Liaoning, China
        Shengjing Hospital of China Medical University
      Apr 13, 2022

      SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )

      Active, not recruiting
      • SGLT2 INHIBITORS
      • +2 more
      • Dapagliflozin tablet
      • placebo
      • Mansoura, Egypt
        Urology and Nephrology Center
      Jan 19, 2023